Literature DB >> 27197644

One Face of Chlamydia trachomatis: The Infectious Elementary Body.

Mathilde M Cossé1,2, Richard D Hayward3, Agathe Subtil4,5.   

Abstract

The lifestyle of Chlamydiae is unique: the bacteria alternate between two morphologically distinct forms, an infectious non-replicative elementary body (EB), and a replicative, non-infectious reticulate body (RB). This review focuses on recent advances in understanding the structure and function of the infectious form of the best-studied member of the phylum, the human pathogen Chlamydia trachomatis. Once considered as an inert particle of little functional capacity, the EB is now perceived as a sophisticated entity that encounters at least three different environments during each infectious cycle. We review current knowledge on its composition and morphology, and emerging metabolic activities. These features confer resistance to the extracellular environment, the ability to penetrate a host cell and ultimately enable the EB to establish a niche enabling bacterial survival and growth. The bacterial and host molecules involved in these processes are beginning to emerge.

Entities:  

Mesh:

Year:  2018        PMID: 27197644     DOI: 10.1007/82_2016_12

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  12 in total

1.  Chlamydia trachomatis recruits protein kinase C during infection.

Authors:  Prakash Sah; Nicholas H Nelson; Jennifer H Shaw; Erika I Lutter
Journal:  Pathog Dis       Date:  2019-08-01       Impact factor: 3.166

2.  Chlamydia trachomatis Requires Functional Host-Cell Mitochondria and NADPH Oxidase 4/p38MAPK Signaling for Growth in Normoxia.

Authors:  Jeewan Thapa; Gen Yoshiiri; Koki Ito; Torahiko Okubo; Shinji Nakamura; Yoshikazu Furuta; Hideaki Higashi; Hiroyuki Yamaguchi
Journal:  Front Cell Infect Microbiol       Date:  2022-05-26       Impact factor: 6.073

3.  Pyocyanin Inhibits Chlamydia Infection by Disabling Infectivity of the Elementary Body and Disrupting Intracellular Growth.

Authors:  Jian Lin Li; Ningjing Yang; Lei Huang; Dandan Chen; Yu Zhao; M Matt Tang; Huizhou Fan; Xiaofeng Bao
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

4.  Glycosylation-dependent galectin-receptor interactions promote Chlamydia trachomatis infection.

Authors:  Agustin L Lujan; Diego O Croci; Julián A Gambarte Tudela; Antonella D Losinno; Alejandro J Cagnoni; Karina V Mariño; María T Damiani; Gabriel A Rabinovich
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-11       Impact factor: 11.205

5.  The DUF582 Proteins of Chlamydia trachomatis Bind to Components of the ESCRT Machinery, Which Is Dispensable for Bacterial Growth In vitro.

Authors:  François Vromman; Stéphanie Perrinet; Lena Gehre; Agathe Subtil
Journal:  Front Cell Infect Microbiol       Date:  2016-10-07       Impact factor: 5.293

6.  Inhibitory Activity of Pyrroloisoxazolidine Derivatives against Chlamydia trachomatis.

Authors:  Min Ni; Shunxin Xu; Ziyi Liu; Yin Xue; Wenxia Xie; Shengju Yang; Lingyan Liu; Xiaofeng Bao
Journal:  Biomed Res Int       Date:  2021-03-13       Impact factor: 3.411

7.  Conservation of the glycogen metabolism pathway underlines a pivotal function of storage polysaccharides in Chlamydiae.

Authors:  Derifa Kadouche; Mathieu Ducatez; Matthieu Colpaert; Trestan Pillonel; Carole Kebbi-Beghdadi; Ugo Cenci; Binquan Huang; Malika Chabi; Emmanuel Maes; Bernadette Coddeville; Loïc Couderc; Hélène Touzet; Fabrice Bray; Catherine Tirtiaux; Steven Ball; Gilbert Greub; Christophe Colleoni
Journal:  Commun Biol       Date:  2021-03-05

8.  The "F" in SAFE: Reliability of assessing clean faces for trachoma control in the field.

Authors:  Sheila K West; Derick Ansah; Beatriz Munoz; Nicodemus Funga; Harran Mkocha
Journal:  PLoS Negl Trop Dis       Date:  2017-11-30

9.  The Loss of Expression of a Single Type 3 Effector (CT622) Strongly Reduces Chlamydia trachomatis Infectivity and Growth.

Authors:  Mathilde M Cossé; Michael L Barta; Derek J Fisher; Lena K Oesterlin; Béatrice Niragire; Stéphanie Perrinet; Gaël A Millot; P Scott Hefty; Agathe Subtil
Journal:  Front Cell Infect Microbiol       Date:  2018-05-15       Impact factor: 5.293

Review 10.  An Ancient Molecular Arms Race: Chlamydia vs. Membrane Attack Complex/Perforin (MACPF) Domain Proteins.

Authors:  Gabrielle Keb; Kenneth A Fields
Journal:  Front Immunol       Date:  2020-07-14       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.